| Literature DB >> 26143582 |
Gerd A Blobel1, David Bodine2, Marjorie Brand3, John Crispino4, Marella F T R de Bruijn5, David Nathan6, Thalia Papayannopoulou7, Catherine Porcher5, John Strouboulis8, Len Zon9, Douglas R Higgs5, George Stamatoyannopoulos7, James Douglas Engel10.
Abstract
Every 2 years since 1978, an international group of scientists, physicians, and other researchers meet to discuss the latest developments in the underlying etiology, mechanisms of action, and developmental acquisition of cellular and systemic defects exhibited and elicited by the most common inherited human disorders, the hemoglobinopathies. The 19th Hemoglobin Switching Conference, held in September 2014 at St. John's College in Oxford, once again exceeded all expectations by describing cutting edge research in cellular, molecular, developmental, and genomic advances focused on these diseases. The conference comprised about 60 short talks over 3 days by leading investigators in the field. This meeting report describes the highlights of the conference.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26143582 PMCID： PMC5490074 DOI： 10.1016/j.exphem.2015.06.008
Source DB: PubMed Journal: Exp Hematol ISSN： 0301-472X Impact factor: 3.084